AzTrials
AzTrials

MotivationCAPNCT05384808

Canine-assisted Psychotherapy Motivation Alliance

A study testing Standard Psychotherapy, Canine-assisted psychotherapy with dog actively integrated. and Canine-assisted psychotherapy with dog passively integrated. in people with Motivation and Alliance, Therapeutic, run by University of Basel at 1 site in Switzerland.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of the study is to investigate the needed extent and the way a dog is integrated into psychotherapeutic interventions for them to be motivating and alliance building for children and adolescents with psychiatric disorders aged 9 to 17 years old. Read more about this study

Who is it for?
Ages 9 to 17 years
Conditions the study is for
Motivation, Alliance, Therapeutic
What is being tested?
Standard Psychotherapy, Canine-assisted psychotherapy with dog actively integrated. and Canine-assisted psychotherapy with dog passively integrated.
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
1 siteSwitzerland
Study dates
1 Jun 2022to 31 Dec 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 9 to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Age between 9 and 17 years
  • Children are seeing the therapist for the first time
  • Basic knowledge of child and parents in either German or English to be able to fill in questionnaires
  • Informed consent given by legal guardian
  • Positive or neutral attitude towards dogs
  • working with an own therapy dog
  • completed therapy training or if not completed far advanced therapy training under supervision
  • working with children and adolescents aged 9 to 17 years

Who cannot join

  • acute psychosis; early childhood autism
  • diagnosed developmental disorder or intellectual delay; if not diagnosed, exclusion when questionnaires cannot be completed due to development level
  • fear of dogs
  • allergic reactions to dogs
  • reported aggressive behavior towards animals in the past
  • not working with an own therapy dog
  • no completed or far advanced therapy training
  • not working with children and adolescents aged 9 to 17 years

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Karin Hediger, Prof. Dr. contact

(+41) 61 207 69 58

karin.hediger@unibas.ch

Wanda Arnskötter, Msc. contact

wanda.arnskoetter@unibas.ch

Switzerland1 site, 1 recruiting
  • University of Basel

    Basel

    Karin Hediger, Prof. Dr.

    Recruiting

Other trials in Switzerland

About this study

Official title: Effects of the Inclusion of a Dog in Psychotherapy on Children's Alliance and Treatment Motivation

The aim of the study is to investigate the needed extent and the way a dog is integrated into psychotherapeutic interventions for them to be motivating and alliance building for children and adolescents with psychiatric disorders aged 9 to 17 years old. Specifically, we want to elaborate if the dog needs to be integrated into the therapy in a form that it is part of the therapeutic context or if the presence of the dog without being part of the therapeutic context per se is beneficial.

Being tested
Standard Psychotherapy, Canine-assisted psychotherapy with dog actively integrated., Canine-assisted psychotherapy with dog passively integrated.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Standard PsychotherapyBehavioural

    Participants receive a standard psychotherapy session with no dog being present.

  • Canine-assisted psychotherapy with dog actively integrated.Behavioural

    A dog is present and actively integrated into the therapeutic narrative.

  • Canine-assisted psychotherapy with dog passively integrated.Behavioural

    A dog is present but not actively integrated into the therapeutic narrative.

Study groups in NCT05384808
Study groupRoleWhat they receive
No dog presentExperimentalConventional psychotherapy with no dog being present.
Receives: Behavioral: Standard Psychotherapy
Dog present and active part of therapeutic narrative.ExperimentalThe dog is actively integrated into the therapeutic narrative.
Receives: Behavioral: Canine-assisted psychotherapy with dog actively integrated.
Dog present but not active part of therapeutic narrative.ExperimentalThe dog is present but not actively integrated into the therapeutic narrative.
Receives: Behavioral: Canine-assisted psychotherapy with dog passively integrated.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Therapeutic alliance of patients

    Patient's reported therapeutic alliance is measured after the first, the third and the fifth therapy session of a newly began psychotherapy using the german adaptation of the "Therapeutic Alliance Scales for Children" (TASC)". The TASC consists of 12 items, answered with a 4 point likert scale. The questionnaire assesses the therapeutic alliance from the perception of the child. Four weeks after the fifth therapy session children will be asked to fill in the questionnaire again as follow-up measurement.

    Measured: 9 weeks

  2. Motivation of patients

    Patient's reported motivation is measured after the first, the third and the fifth therapy session of a newly began psychotherapy using the "Situational Motivation Scale for children (SMS-15)". The SMS-15 consists of 15 items answered with a 7 point likert scale. Four weeks after the fifth therapy session, children will be asked to fill in the questionnaire again as follow-up measurement.

    Measured: 9 weeks

Secondary outcomes (2)
  1. Treatment satisfaction of patients

    Treatment satisfaction of children is measured after the fifth therapy session as well as four weeks after as follow up using the "treatment assessment questionnaire (FBB)". The FBB consists of 20 items answered with a 5 point likert scale.

    Measured: 4 weeks

  2. Number of missed sessions

    Number of missed sessions and drop-outs will be documented for each child participating in the study.

    Measured: 5 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 May 2022
  2. Study start1 Jun 2022
  3. Primary completion31 Mar 2025 (estimated)
  4. Study completion31 Dec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05384808
Sponsor's protocol ID
2022-00304
Acronym
CAP
Status last verified
Jul 2024
First submitted
2 May 2022
Last updated
18 Jul 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Arnskotter W, Martin S, Walitza S, Hediger K. Effects of including a dog on treatment motivation and the therapeutic alliance in child and adolescent psychotherapy: study protocol for a randomized controlled trial. Trials. 2024 Jan 5;25(1):26. doi: 10.1186/s13063-023-07854-4.

    PubMed 38183121

Questions about this trial

What is this clinical trial studying?

A study testing Standard Psychotherapy, Canine-assisted psychotherapy with dog actively integrated. and Canine-assisted psychotherapy with dog passively integrated. in people with Motivation and Alliance, Therapeutic, run by University of Basel at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 18 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Karin Hediger, Prof. Dr. ((+41) 61 207 69 58, karin.hediger@unibas.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Therapeutic alliance of patients (time frame: 9 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05384808, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jul 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in